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Objectives: To compare (i) the in vivo release of fluoride from fluoridated elastomers to the in vitro
release, and (ii) the residual fluoride content of the elastomers after 1 week in the mouth with and
without fluoride toothpaste and mouthrinse.
Design: A prospective, longitudinal, cross-over study.
Subjects and method: Six subjects were recruited by poster to take part in the study. Each subject
had one premolar in each quadrant to which a bracket could be fixed and exemplary oral hygiene.
Elastomers were then placed on these brackets.
Intervention: The study was divided into two parts: (i) subjects used oral hygiene products with
fluoride and (ii) oral hygiene products with fluoride were excluded. Both groups of elastomers
were left in the mouth for 1 week. After collection the elastomers were stored in distilled water.
Main outcome measures: The amount of residual fluoride in the ligatures after they have been
placed in the mouth for 1 week was compared with the cumulative fluoride release in vitro over 1
week and 6 months.
Results: Only 13 per cent of the total amount of fluoride in fluoridated elastomers was released
during the first week in vitro, compared with 90 per cent in vivo. There was a significantly greater
amount (P = 0.001) of residual fluoride when the elastomers were in the mouth for 1 week in the
presence of fluoride toothpaste and mouthrinse, than when fluoride supplements were excluded. 
Conclusions: (1) Higher levels of fluoride are lost from the fluoride elastomers in vivo than in vitro
during the first week. (2) A significantly greater amount of residual fluoride was released from the
elastomers placed in the mouth when fluoride toothpaste and mouthrinse were used.
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Introduction
Fluoride supplements have been shown to reduce the
incidence of demineralization during orthodontic treat-
ment.1,2 One problem with these methods of adminis-
trating fluoride is that they are dependent on patient
compliance.
Recently, elastomers that release stannous fluoride
have been made available for orthodontic patients. The
elastomers leach fluoride close to the site of vulnerability
next to the bracket. Because they are changed every 4–6
weeks, they may be the perfect vehicle to provide a low
concentration of fluoride over a period of orthodontic
treatment. Clinical studies using these elastomers have
shown promising results with a reduction in the pre-
valence3 and severity4 of demineralization during ortho-
dontic treatment. In vitro studies, however, have shown
that although the fluoride release is initially high it soon
becomes low and not sustainable over clinically relevant
time periods.5
To-date few studies have examined the in vivo fluoride
release from fluoridated ligatures. Wiltshire6 has sug-
gested that the fluoridated elastomers absorb fluoride 
in the mouth, as well as release it. This has also been
demonstrated with some of the dental cements.7 It would
obviously be difficult to directly measure the amount of
fluoride released or absorbed from the elastomers in vivo.
However, by measuring the amount of fluoride left in the
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elastomers after they have been in the mouth for a period
of time and comparing this with the total amount of
fluoride released from the elastomers in vitro, it should be
possible to provide an indirect estimate of the amount of
fluoride released. Further to this, the in vitro part of the
study will also allow comparisons to be made between the
fluoride release into a test tube to that in the mouth.
The aims of this in vivo study were:
• to compare the amount of fluoride released from
fluoridated elastomers placed in the mouth for 7 days
with similar elastomers placed in distilled water;
• compare the amount of residual fluoride released from
fluoridated elastomers placed in the mouth for 7 days
when fluoride supplements were used with similar
elastomers placed without the use of fluoride supple-
ment.
Materials and methods
Ethical approval was obtained from the South Sheffield
Research Ethics Committee. They made the proviso that
a poster should be used to recruit volunteers. A sample
size calculation showed that five individuals were needed
to show a difference of 0.56 gF/ml/elastomer, to a power
of 0.95 and significance of 0.01.
The study group 
Six subjects (three males, three females) were recruited to
take part in the study. Subjects were eligible for inclusion
if they had at least one premolar in each quadrant, to
which a bracket could be fixed and their oral hygiene was
of an exemplary standard. For all the subjects that were
eligible for inclusion, the trial was explained and each
received a patient information sheet. At the next appoint-
ment written consent was obtained. 
The intervention
Each subject had an orthodontic bracket (GAC inter-
national. Inc, 185 Oval Drive, Islanda, NY 11749) placed
onto a premolar in each quadrant (Figure 1). Standard
methods and materials were used to place the bracket,
including the use of 30 per cent phosphoric etchant gel to
treat the surface of the premolar. They were attached with
a non-fluoride leaching composite bonding cement (Rely-
a –Bond®, Reliance Ortho Prod. Inc., Itasca, IL, USA).
Following bracket placement the subjects were given oral
hygiene instruction. All subjects were asked to maintain
good oral hygiene for the duration of the study.
The in vivo study with fluoride supplements. One fluorid-
ated elastomer (Fluor-I-Ties®, Ortho Arch Company
Inc) was tied onto each of the four brackets and left in 
the mouth for 7 days. During this period, the subjects
were asked to use a standardized fluoridated mouthwash
(Colgate FluoriGard®, Sodium fluoride 0.05 per cent,
Colgate Palmolive (UK) Manchester M5 3FS) and tooth-
paste (Colgate Fluoride toothpaste, Sodium mono-
fluorophosphate 1000 ppm, sodium fluoride 450 ppm).
The subjects were asked to use these products at set times
of the day, namely 7.30 a.m. and 7.30 p.m.
The elastomers were removed after 7 days, then rinsed
with distilled water to remove debris and protein accumu-
lations. The four ties from each volunteer were placed
collectively into an air-tight, polyethelene beaker con-
taining 10 ml of distilled water and stored at room
temperature.
The in vivo study without fluoride supplements. The
method outlined above was repeated, except for the 
7-days that the elastomers were left in the mouth the
subjects were prescribed a non-fluoridated mouthwash
and toothpaste (Sainsbury’s Confident Naturally Fresh,
Stamford Street, London SE11 9LL). Subjects were 
also asked to avoid other fluoride supplements for the
duration of the study.
Fluoride analysis
In order to calculate the fluoride concentrations of the
distilled water a fluoride/fluoride combination electrode
(Thermo Orion) was used. The electrode was connected
to a pH/mV with readability to 0.1 mV. Before analysing
the samples the electrode was calibrated, using two stand-
Fig. 1 Brackets positioned on the premolars, with fluoridated elastomers
in place.
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ard solutions of fluoride (1 and 10 ppm). To maintain a
standard pH all solutions were mixed with equal amounts
of total ionic solution adjustment buffer (TISAB II).
Calibration of the electrode was repeated every 2 hours to
ensure the readings were accurate and consistent.
The in vivo elastomers. Fluoride analysis was carried out
incrementally (approximately every 6 weeks) over 6
months until most of the fluoride had been released. Six
weeks was considered to be a sufficiently long time period
to allow fluoride to leach out of the elastomers without
allowing super saturation of the solutions. At each of the
analysing sessions the four elastomers were removed
from each sample and transferred to a fresh beaker
containing 10 ml of distilled water. The new sample was
then stored for a further 6 weeks in the laboratory before
analysis. A 1-ml pipette was used to draw equal quantities
of the solution under test (taken from the original beaker)
and TISAB II, which were mixed together in a disposable
container. This solution was then analysed with the
fluoride electrode and once the voltmeter had stabilized,
the reading was recorded. Between readings the electrode
was carefully cleaned with distilled water and dried with 
a tissue. At the completion of each session the electrode
was cleaned and stored according to the manufacturers
instructions.
The in vitro elastomers. Four elastomers were placed onto
orthodontic brackets, with 1 ml of distilled water in a
polyethelene beaker and stored in an incubator at 37C.
The fluoride/fluoride combination electrode was used to
analyse the fluoride content of the distilled water after 24
hours. The same four elastomers were placed in a fresh 
1-ml sample of distilled water and again stored for 24
hours. The fluoride concentration of the distilled water
was again measured. Daily measurements of fluoride
release were carried out during the first week. This was
followed by incremental measurements over the next 6
months until it was considered that most of the fluoride
had been released from the elastomers.
Throughout the testing period of the study a distilled
water control was used. This was obtained from the same
source as the water used as the storage medium for the
elastomers. The same conditions were applied to the
control as to the solutions under test.
Statistical testing
The following statistics were employed in this study:
1. The total amount of fluoride released in vitro was
calculated by adding the areas under the curve (AUC)
between each pair of observations as follows. If we
have fluoride concentrations y1 and y2 at times t1 and t2,
the AUC between those two times is the product of the
time difference and the average of the two measure-
ments. Thus, we get:
(t2 – t1) (y1 + y2)/2
This is known as the trapezium rule because of the shape
of each segment of the area of the curve. The total amount
of fluoride left in the in vivo elastomers was calculated by
adding the incremental fluoride measurements taken over
the 6 months.
2. To test the null hypothesis that there was no difference
between the fluoride released from the elastomers worn
during the fluoride supplement period compared with
the non-fluoride supplement period, a paired t-test 
was used. Prior to testing, the data was examined for
normality using the Shapiro–Wilks test.
Results
The mean total fluoride concentration per module in vitro
over the 6-months for each of the ten groups is shown 
in Table 1. The mean area under the curve for the 10
samples was 138.65 gF/day/ml/elastomer (SD 3.75). The
mean total amount of fluoride available for release from
each ligature was therefore 0.139 mg. The in vitro mean
cumulative 7-day fluoride concentration per module 
was 18.07 gF/ml/elastomer. The mean total amount of
Table 1 The cumulative fluoride concentration
per elastomer (gF/day/ml/elastomer) from 10 in
vitro samples of fluoridated elastomers over 6
months calculated using the area under the curve
(AUC) method
Sample number AUC 
1 140.26
2 139.14
3 130.91
4 138.55
5 137.82
6 135.39
7 144.17
8 139.64
9 141.95
10 142.01
Mean 138.65
SD 3.75
95% CI 136.30–141.67
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fluoride released from each ligature during the first 7 days
in vitro was therefore 0.018 mgF. Hence, 13 per cent of the
available fluoride was released during the first week in
vitro.
The cumulative residual fluoride concentration from
the elastomers that had been placed in the mouth is 
shown in Table 2. The mean cumulative residual fluoride
concentration was 13.30 gF/ml/elastomer (SD 0.74) for
the fluoride elastomers worn without fluoride supple-
ments and 15.85 gF/ml/elastomer (SD 0.72) for those
worn with fluoride supplements. The mean total amount
of residual fluoride in each elastomer was therefore 
0.013 mg for the fluoride elastomers worn without
fluoride supplements and 0.016 mg for those worn with
fluoride supplements.
To calculate the amount of fluoride lost in the mouth
during the first week a subtraction method was used. The
mean total amount of residual fluoride from the in vivo
part of the study was subtracted from the mean total
amount of fluoride from the in vitro part of the study. The
mean total amount of fluoride in each elastomer calcu-
lated in vitro was 0.139 mg. The mean residual amount of
fluoride per elastomer was 0.013 mg for the fluoride
elastomers worn without fluoride supplements. The
difference in these amounts is very large, and suggests
that over 0.12 mg of fluoride or 90 per cent of the
available fluoride was lost per module, in the mouth of
each volunteer during the first week.
Throughout the study a control was used. This was
distilled water obtained from the same source as that used
for the fluoride analysis. The fluoride levels remained
constant and extremely low (<0.02 gF/ml) for the whole
study indicating that the increase in fluoride was coming
solely from the elastomers and not from any other source
(i.e. the beaker).
At the end of the 6-month experimental period both in
vivo and in vitro samples were still releasing a low level of
fluoride. To ensure that the amount of residual fluoride
was the same for both the in vivo and in vitro elastomers
the samples were placed in fresh distilled water and the
fluoride concentration was tested after 24 hours. The
fluoride release was found to be the same for both the 
in vivo (0.41 gF/ml/elastomer) and in vitro groups 
(0.41 gF/ml/elastomer). Therefore, as the amount was
small and similar in both groups it was considered
possible to compare the results from the two groups.
The effect of fluoride supplementation on the in vivo
modules
To test the hypothesis that there was a difference in 
the residual fluoride concentration between the in vivo
elastomers collected with fluoride supplements compared
with the elastomers collected without fluoride supple-
ments the data were first checked for normality using the
Shapiro–Wilks test. This test was non-significant thus
allowing the paired t-test to be utilized. The mean differ-
ence, standard deviation and 95 per cent confidence limits
of the differences between the two groups are shown in
Table 3. The significance level (P = 0.001) indicates very
strong evidence that there is a difference between the
residual fluoride levels in the two groups.
Discussion
The results of this study suggest that fluoride is released
from fluoridated elastomers more rapidly when placed in
the mouth compared with in the test tube. The amount 
of fluoride released from each elastomer in vivo was
approximately 0.12 mg. If the average orthodontic
Table 2 Cumulative residual fluoride concentration per
module (gF/ml/elastomer) measured over 6 months for
fluoridated elastomers worn by six individuals for 1
week, with and without fluoride mouthwash and
toothpaste
Subject Without fluoride With fluoride 
supplements supplements
1 13.44 16.23
2 14.12 16.43
3 12.96 15.83
4 12.00 15.73
5 13.71 16.38
6 13.58 14.50
Mean 13.30 15.85
SD 0.74 0.72
95% CI 13.25–14.12 14.76–15.54
Table 3 Mean difference, standard deviation, 95 per cent CI and results
of paired t-test for the cumulative residual fluoride concentration per
elastomer (gF/ml/elastomer) measured over 6 months from the
fluoridated elastomers worn by six individuals for 1 week, with and
without fluoride toothpaste and mouthrinse
Paired differences Mean difference –2.55
Standard deviation 0.93
Standard error of the mean 0.38
95% CI Lower –3.52
Upper –1.58
Significance 0.001
patient has 20 modules placed at each appointment, 
2.4 mg of fluoride is released during the first week in the
mouth. It has been suggested that the daily intake of
fluoride in children should not exceed 0.10 mg/kg of body
weight.8 If the release of fluoride quickly drops off after
the first few days, the fluoride release may be extremely
high immediately after the elastomers are placed. Caution
is warranted when using these modules, particularly for
younger patients, those with an already high fluoride
intake from other sources, such as fluoride supplements
or in areas where the water is fluoridated. One solution to
reduce this initial high dose of fluoride is to place them
only on the teeth at risk of demineralization or alternate
them with regular modules. Further work is required to
investigate fluoride loss from these elastomers in the first
24 hours after placement.
Another finding of this investigation was that there is 
a significant difference in the amount of residual fluoride
in the modules when fluoride supplements were used
compared with when they were avoided by the subjects.
This confirms work carried out previously,6 which sug-
gested that the modules not only release fluoride, but also
absorb it from their environment. One criticism of the
fluoridated elastomers is that their ability to release
fluoride is not sustainable over time.5 If the modules 
are able to recharge with fluoride introduced into the
environment from toothpastes or mouthwashes, then
sufficient amounts of fluoride might be released over
longer time periods to prevent demineralization. Several
factors are likely to be involved in this recharge,7 includ-
ing the permeability of the material, and the form and
concentration of the fluoride used; however, this study
appears to suggest that the elastomers do have a recharge
potential. The clinical significance of this recharge poten-
tial is speculative. The patients who are susceptible to
demineralization are likely to be non-compliant having
an irregular intake of fluoride from toothpastes or mouth-
washes. Ideally, there should be sufficient amounts of
fluoride released from the elastomers over clinically
relevant time periods to prevent demineralization with-
out relying on fluoride recharge. 
The pattern of fluoride release in the in vitro part of 
this study was similar to that reported by Wiltshire.5
However, the amount of fluoride released at each time
interval in this study was much higher. 
One explanation for this finding is that the elastomers
may not be the same in both studies. The appearance of
the elastomers certainly has changed; instead of being
injection moulded they are now cut from a tube. This is
illustrated in Figure 2.
It is likely that not only has the appearance of the
modules changed since Wiltshire’s work, but so have their
physical and chemical properties. Several clinicians have
found that the original fluoridated elastomers performed
poorly in the mouth.3,9 They reported high breakages and
unacceptable swelling of the modules. Wiltshire6 found
that they swelled and doubled in weight after 4 weeks in
the mouth, whereas little change was measured with con-
ventional elastomers. It is possible that the manufacturer
has addressed these problems and changed the elasto-
mers. It would appear that elastomers produced by a die
punching technique are 50–80 per cent stronger than
those produced by injection moulding.10 From their
appearance the elastomers have changed from injection
moulded to die punched.
It was found that, even after 6 months, the elastomers
were still releasing fluoride; therefore, our calculation of
the total amount of fluoride available for release from
each elastomer might be an underestimation. This is
possibly because there is an outer, loosely bound layer of
fluoride that is released initially and an inner, more tightly
bound core of fluoride that is released more slowly.
However, because the 24-hour release from the in vivo and
in vitro elastomers was the same after 196 days, there is
likely to be a similar amount of fluoride left in both
groups of elastomers; therefore, the proportion of
fluoride released after 7 days in the mouth will not be
altered.
Although 90 per cent of the fluoride is released during
the first week in the mouth, the remaining 10 per cent
might be released more slowly and could be sufficient to
reduce the prevalence and severity of demineralization.3,4
Margolis et al.11 found that concentrations of fluoride as
low as 0.024 ppm offered ‘remarkable protection’ of the
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Fig. 2 Recent change in physical appearance of the elastomers.
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enamel surface in vitro. If this is true in vivo, then it is likely
that fluoridated elastomers, particularly combined with
fluoride toothpaste and mouthrinse, will raise the fluoride
level in plaque sufficiently to enhance remineralization.
This would be a useful area of further investigation.
This study had a small sample size, but one surprising
finding was that the variability in the amount of residual
fluoride left in the elastomers after 1 week was low
between individuals. This suggests that the fluoride
release from these modules is consistent regardless of
differences in diet, flow of saliva and fluoride clearance
patterns. Because this variability was low, the power of
the study was sufficient to show a positive difference in
the residual fluoride when fluoride supplements were
used.
This study explored fluoride release from fluoridated
elastomers after 1 week in the mouth. Further investi-
gations leaving them in place in the mouth for 2, 3, 4, and
6 weeks are warranted. This would enable the rate of
fluoride release to be more accurately profiled and help
ascertain the optimal period for replacing fluoridated
elastomers in the clinical situation. It would also be
interesting to determine if non-fluoridated elastomers
have the same recharge potential.
Conclusions
1. In the first week after placement, fluoridated elasto-
mers release high levels of fluoride.
2. The in vitro and in vivo fluoride release does not appear
to be similar.
3. There was a significantly greater amount (P = 0.001) 
of residual fluoride when the elastomers were in the
mouth for 1 week in the presence of fluoride containing
hygiene products than when they were excluded.
4. Fluoridated elastomers may imbibe fluoride from their
environment.
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